CEO & Co-Founder
CEO & Co-Founder of Asana Bio Group, a holding company specializing in scientific advancements in the field of cannabinoids.
Former CEO of Lumir Lab, a global leading R&D lab, providing evidence-based cannabinoids R&D solutions for key players in the field.
VP R&D
Dr. Prutchi-Sagiv has over 15 years of experience in various aspects of pharmaceutical development including preclinical and clinical studies, regulatory affairs and IP. Over the last 10 years, Dr. Prutchi-Sagiv has lead scientific operations in multiple cannabinoids-based drug companies including Kalytera, Talent Biotechs, Stero Biotechs and BOL Pharma. She also serves as Director of Tech Transfer at Mor Research Applications (Clalit Health Services commercializing arm), where she is responsible for the pharma and diagnostics department.
CTO
Former COO and CTO of Sol-Gel Technologies Ltd., a Nasdaq traded pharmaceutical company. Haim has more than 20 years’ experience in formulation and delivery system development, process development, scale-up and microencapsulation technologies.
VP Strategy
Former CEO of InPlant Technologies Ltd, a startup company that developed novel formulations for improved delivery of fertilizers and agrochemicals. Before that, Lenore served for as VP New Ventures at the Trendlines Agtech technology incubator, and before that as Strategy Manager at Chiasma.
President
Prof. Hod is a global opinion leader in the field of women’s health and the President of the European Association of Perinatal Medicine (EAPM). A Professor of Obstetrics and Gynecology at the Sackler Faculty of Medicine, Tel-Aviv University, Prof. Hod serves as a Chief Consultant for Perinatal Medicine to Clalit Health Services, Israel’s largest health organization, and the Director of Mor Women’s Health Center.
CEO & Founder of PQE Group, with 34 global offices around the world, 21 legal entities, and 2000 employees, involved in pharmaceutical regulation, quality & compliance.
Lenore co-founded the Group for ADHD, LLC, a multi-disciplined clinic providing full diagnostics and treatment for adults, children, and families living with ADHD and/or learning disabilities dedicated to providing a combination of both traditional and alternative treatments. Ruben serves as the President of ELEM America, a nonprofit organization committed to treating and transforming the lives of troubled youth, is a member of the Hillel International Board of Governors, and sits on the board of the Bronfman Center at NYU.
Meredith Rose Burak, former executive at Merrill Lynch, facilitates innovative solutions across the fields of advocacy, philanthropy and for-profit investing to create worldwide economic and political change. Meredith provided strategic investment and philanthropic advice to her clients, managing hundreds of millions of dollars in assets. In honor of her mother, Meredith founded and presides over the Mary Haas Ovarian Cancer Early Detection Foundation to fund awareness and research initiatives to combat the disease. Passionate about education and empowering future leaders, Burak is the youngest professional on the board of directors of Hillel International.
Dr. Kaufman is a Senior Consultant at the Department of Obstetrics & Gynecology at Carmel Medical Center and Assuta Private Hospital. He also founded and heads the Multidisciplinary Center for the Treatment of Endometriosis, the leading center for patients with endometriosis in the north of Israel. Dr. Kaufman is a Clinical Lecturer at Technion (Israel Institute of Technology), a member of the European and American Endoscopy societies (ESGE and AAGL) and the World Endometriosis Society (WES).
